Sterling Drug Inc said it submitted anew drug application to the Food and Drug Administration forpermission to market an oral form of Corotrope (milrinone), adrug for treating chronic congestive heart failure.    Sterling said the application includes a series of studiesof 952 patients and results of three multicenter studiesinvolving another 571 patients, to demonstrate the efficacy andsafety of the drug as an alternative to digitalis. Reuter&#3;